While C3 DLBCL is clearly enriched for mutations in genes encoding epigenetic modifiers, transcription factors and BCL2, two additional genes with different functions are also recurrently altered in C3 DLBCL and will be discussed briefly. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.